Patent Attorney

Newcastle Office


Telephone. +44(0) 191 205 8360
Email. [email protected]


Elliot works in the engineering group and has particular expertise in the automotive, bioengineering and medical device sectors. He also utilises his background in chemistry to advise on pharmaceutical and chemical composition patent applications.

Elliot works closely with all types of clients, from start-ups and Universities to large corporations, to develop a bespoke IP strategy suited to their current and future commercial needs. His day-to-day work involves leading the patent prosecution for a global supplier in the automotive sector, advising on IP strategy and FTO for biotech companies working towards IPO, and working on oppositions before the European Patent Office.

Elliot's aim is to support his clients on their business journey by working closely with them to capture and protect their IP, and develop an appropriate IP strategy to ensure that they meet their commercial goals.


Patent Attorney

Chartered (UK)


Chemistry and Medicinal Chemistry


Intellectual Property


IP Litigation Certificate


Friere-Marreco Medal and Excellence Prize

Elliot was awarded this prize from Newcastle University as part of his academic research into polymorphism of compounds and its application to intellectual property rights. In particular, his work focused on X-ray crystallographic studies of naproxen and other NSAIDs.


Elliot is the North East regional secretary of the CIPA informals, a body which represents trainee patent attorneys. As part of this role, he raises issues affecting trainees in his area, as well as organising social gatherings and sharing best practice.

Related News

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.